CKD增加HDL羰基化并与抗聚集特性受损相关
该研究利用CKD(5/6肾切除)兔模型及健康志愿者、血液透析和腹膜透析患者的血样,发现CKD兔和血液透析患者的HDL存在HNE加合物,且其抑制血小板聚集和活化的能力受损;HNE修饰的HDL同样导致血小板聚集和活化增加,而阻断CD36或SRC激酶可恢复抗聚集表型。
要点
- CKD兔和血液透析患者的HDL携带HNE加合物,抗血小板聚集功能受损。
- HNE修饰的HDL可增强胶原诱导的血小板聚集和活化。
- 阻断CD36或抑制SRC激酶可恢复CKD及HNE修饰HDL的抗聚集表型。
核心结论
- CKD兔和血液透析患者的HDL抑制血小板聚集的能力受损,提示HDL性质改变可能 contribute to 该人群心血管风险增加。
研究设计与样本
- CKD(5/6肾切除)兔模型,以及15名健康志愿者、25名血液透析患者和20名腹膜透析患者的离体血样。
主要发现
- CKD兔和血液透析患者的HDL存在HNE加合物。
- 与对照组HDL相比,CKD兔和血液透析组HDL孵育的血小板经胶原诱导的聚集或活化百分比显著更高。
- 在兔和人类中,HNE修饰的HDL存在时血小板聚集和活化显著高于各自对照HDL。
- 用抗CD36阻断抗体或SRC激酶药理抑制剂孵育血小板,可在CKD兔、血液透析和腹膜透析患者HDL以及HNE修饰HDL存在时恢复抗聚集表型。
临床怎么用
- CKD患者HDL抗血小板聚集功能受损,可能参与心血管风险增加,需关注HDL功能而非仅水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CKD is associated with increased oxidative stress that correlates with occurrence of cardiovascular events. Modifications induced by increased oxidative stress particularly affect circulating lipoproteins such as HDL that exhibit antiatheromatous and antithrombotic properties in vitro. METHODS: To explore the specific role of oxidative modifications of HDL in CKD and their effect on the platelet-targeting antiaggregant properties of HDL, we used a CKD (5/6 nephrectomy) rabbit model. For ex vivo assessment of the antiaggregant properties of HDL, we collected blood samples from 15 healthy volunteers, 25 patients on hemodialysis, and 20 on peritoneal dialysis. We analyzed malondialdehyde, 4-hydroxynonenal (HNE), and 4-hydroxy-2-hexenal protein adduct levels. Platelet aggregation and activation were assessed by aggregometry, thromboxane B2 assay, or FACS. We modified HDL from controls by incubating it overnight at 37°C with 100 µM of HNE. RESULTS: HDL from CKD rabbits and patients on hemodialysis had HNE adducts. The percentage of platelet aggregation or activation induced by collagen was significantly higher when platelets were incubated with HDL from CKD rabbit and hemodialysis groups than with HDL from the control group. In both rabbits and humans, platelet aggregation and activation were significantly higher in the presence of HNE-modified HDL than with HDL from their respective controls. Incubation of platelets with a blocking antibody directed against CD36 or with a pharmacologic inhibitor of SRC kinases restored the antiaggregative phenotype in the presence of HDL from CKD rabbits, patients on hemodialysis and peritoneal dialysis, and HNE-modified HDL. CONCLUSIONS: HDL from CKD rabbits and patients on hemodialysis exhibited an impaired ability to inhibit platelet aggregation, suggesting that altered HDL properties may contribute to the increased cardiovascular risk in this population.
引用
- Florens N, Calzada C, Lemoine S, et al. CKD Increases Carbonylation of HDL and Is Associated with Impaired Antiaggregant Properties. J Am Soc Nephrol. 2020. PMID: 32518085. doi:10.1681/ASN.2019111205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。